Ophiomics develops innovative products to address clear and pressing medical needs. Our cutting-edge, global reach products combine state-of-the-art biomarkers with machine learning algorithms to provide decisive and actionable information to cancer patients, their physicians, and payers. By leveraging our advanced technology, we are able to make significant improvements to risk and treatment outcome decisions, ultimately leading to better patient outcomes and a reduction in healthcare costs